Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EBIT: 2012-2025

Historic EBIT for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $22.9 million.

  • Veracyte's EBIT rose 90.95% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 205.17%. This contributed to the annual value of $16.1 million for FY2024, which is 118.81% up from last year.
  • Veracyte's EBIT amounted to $22.9 million in Q3 2025, which was up 535.57% from -$5.3 million recorded in Q2 2025.
  • Over the past 5 years, Veracyte's EBIT peaked at $22.9 million during Q3 2025, and registered a low of -$45.4 million during Q1 2021.
  • Over the past 3 years, Veracyte's median EBIT value was -$4.7 million (recorded in 2024), while the average stood at -$4.5 million.
  • Per our database at Business Quant, Veracyte's EBIT slumped by 555.11% in 2023 and then spiked by 162.37% in 2025.
  • Quarterly analysis of 5 years shows Veracyte's EBIT stood at -$12.3 million in 2021, then soared by 56.05% to -$5.4 million in 2022, then crashed by 555.11% to -$35.5 million in 2023, then skyrocketed by 111.76% to $4.2 million in 2024, then soared by 90.95% to $22.9 million in 2025.
  • Its EBIT was $22.9 million in Q3 2025, compared to -$5.3 million in Q2 2025 and $2.9 million in Q1 2025.